Researchers collected data on 2,144 medical device recalls from 2002 to 2015 and used “accelerated failure time models” to see how CEO stock ownership could affect time of recalls. The study found a positive correlation between higher CEO shares and slower recall notices, and the more severe the recall, the slower the alert.
In one case, a medical devicemaker CEO with 2 percentage points of a higher stake than another CEO was associated with 26 more days before a recall was posted, according to an Aug. 3 report on the study from The Wall Street Journal.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.